APPLIED DNA SCIENCES INC's ticker is APDN and the CUSIP is 03815U201. A total of 37 filers reported holding APPLIED DNA SCIENCES INC in Q3 2016. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $31,000 | -16.2% | 10,861 | -47.9% | 0.00% | – |
| Q2 2017 | $37,000 | -2.6% | 20,863 | -9.6% | 0.00% | – |
| Q1 2017 | $38,000 | +52.0% | 23,075 | +68.7% | 0.00% | – |
| Q4 2016 | $25,000 | -28.6% | 13,678 | +20.6% | 0.00% | – |
| Q3 2016 | $35,000 | -14.6% | 11,338 | -5.5% | 0.00% | – |
| Q1 2016 | $41,000 | +5.1% | 11,992 | +0.8% | 0.00% | – |
| Q4 2015 | $39,000 | -83.0% | 11,892 | -73.5% | 0.00% | – |
| Q3 2015 | $230,000 | -13.2% | 44,826 | -47.5% | 0.00% | – |
| Q2 2015 | $265,000 | +7.7% | 85,335 | -10.0% | 0.00% | – |
| Q1 2015 | $246,000 | +115.8% | 94,797 | +141.2% | 0.00% | – |
| Q4 2014 | $114,000 | – | 39,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Benchmark Capital Advisors | 180,000 | $549,000 | 0.41% |
| CHASE INVESTMENT COUNSEL CORP | 77,563 | $236,000 | 0.10% |
| Crosspoint Capital Strategies, LLC | 19,321 | $59,000 | 0.08% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 20,921 | $64,000 | 0.03% |
| REILLY FINANCIAL ADVISORS, LLC | 50,000 | $153,000 | 0.03% |
| Onex Canada Asset Management Inc. | 20,000 | $60,000 | 0.01% |
| WILLIAMS JONES & ASSOCIATES LLC | 48,050 | $147,000 | 0.00% |
| D. SCOTT NEAL, INC. | 384 | $1,000 | 0.00% |
| OPPENHEIMER & CO INC | 13,527 | $41,000 | 0.00% |
| Creative Planning | 56,234 | $172,000 | 0.00% |